State Street’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,074,189
| Closed | -$146M | – | 3937 |
|
|
2020
Q3 | $146M | Sell |
1,074,189
-42,371
| -4% | -$4.5M | 0.01% | 795 |
|
|
2020
Q2 | $108M | Buy |
1,116,560
+131,502
| +13% | +$11M | 0.01% | 911 |
|
|
2020
Q1 | $46.2M | Sell |
985,058
-3,899
| -0.4% | -$250K | ﹤0.01% | 1308 |
|
|
2019
Q4 | $72.1M | Buy |
988,957
+14,185
| +1% | +$860K | ﹤0.01% | 1268 |
|
|
2019
Q3 | $50.8M | Sell |
974,772
-12,528
| -1% | -$666K | ﹤0.01% | 1425 |
|
|
2019
Q2 | $49.5M | Buy |
987,300
+210,775
| +27% | +$10.3M | ﹤0.01% | 1494 |
|
|
2019
Q1 | $40.4M | Buy |
776,525
+47,094
| +6% | +$2.17M | ﹤0.01% | 1576 |
|
|
2018
Q4 | $35.6M | Sell |
729,431
-8,771
| -1% | -$483K | ﹤0.01% | 1568 |
|
|
2018
Q3 | $48.1M | Buy |
738,202
+61,060
| +9% | +$3.59M | ﹤0.01% | 1560 |
|
|
2018
Q2 | $33.6M | Buy |
677,142
+192,237
| +40% | +$9.31M | ﹤0.01% | 1768 |
|
|
2018
Q1 | $23.7M | Buy |
484,905
+15,679
| +3% | +$815K | ﹤0.01% | 1929 |
|
|
2017
Q4 | $19.8M | Buy |
469,226
+119,560
| +34% | +$4.61M | ﹤0.01% | 2052 |
|
|
2017
Q3 | $15M | Buy |
349,666
+117,085
| +50% | +$3.74M | ﹤0.01% | 2217 |
|
|
2017
Q2 | $3.05M | Buy |
232,581
+34,533
| +17% | +$455K | ﹤0.01% | 2958 |
|
|
2017
Q1 | $2.61M | Buy |
198,048
+19,859
| +11% | +$254K | ﹤0.01% | 2990 |
|
|
2016
Q4 | $2.31M | Buy |
178,189
+34,609
| +24% | +$533K | ﹤0.01% | 3044 |
|
|
2016
Q3 | $2.35M | Buy |
143,580
+24,402
| +20% | +$441K | ﹤0.01% | 2914 |
|
|
2016
Q2 | $1.48M | Buy |
119,178
+54,743
| +85% | +$684K | ﹤0.01% | 3150 |
|
|
2016
Q1 | $690K | Buy |
64,435
+15,600
| +32% | +$142K | ﹤0.01% | 3294 |
|
|
2015
Q4 | $714K | Buy |
+48,835
| New | +$597K | ﹤0.01% | 3279 |
|
State Street's MYOK Position: Q4 2020 in Review
State Street sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,074,189 shares — an estimated $146M sold.
State Street first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $146M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- State Street reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- State Street sold 1,074,189 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $146M.
- State Street first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- State Street's MyoKardia, Inc. Common Stock position peaked at $146M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on State Street's 13F filing for Q4 2020, filed 16 Feb 2021.